Dupixent Cancer Lawsuit Claims Eczema Drug Caused Woman’s CTCL Diagnosis

Summary

A Delaware woman has filed a Dupixent lawsuit, claiming manufacturers promoted the eczema drug as a breakthrough treatment while failing to warn that it may trigger or worsen CTCL, a rare form of non-Hodgkin’s lymphoma.